Literature DB >> 24455848

Markers of insulin resistance in perimenopausal women with endometrial pathology.

Olga Kacalska-Janssen1, Agnieszka Rajtar-Ciosek2, Andrzej Zmaczyński2, Jakub Wyroba2, Tomasz Milewicz2, Magdalena Krzyczkowska-Sendrakowska2, Józef Krzysiek2.   

Abstract

OBJECTIVES: To determine and compare the prevalence of insulin resistance and carbohydrate metabolism parameters in women with endometrial pathology
MATERIAL AND METHODS: 100 perimenopausal women with abnormal uterine bleeding and/or abnormal endometrium were included into the study. Hysteroscopy with biopsy was performed. The study population was divided into four groups according to histopathological results of the endometrium: non-atypical endometrial hyperplasia, endometrial polyp, endometrial cancer and controls. Fasting glucose and insulin levels and OGTT, IR indexes, occurrence of diabetes, pre-diabetic state, overweight, obesity and hypertension were assessed.
RESULTS: Insulin resistance was diagnosed in 41.0% of the patients. The prevalence of markers of insulin resistance increased to 57.1% in cases with confirmed endometrial pathology compared to 31.8% in histologically normal endometrium (p<0.01). The frequency of insulin resistance was 52.6% (p=0.059) and 55.5% (p=0.04), respectively in women with non-atypical hyperplasia and patients with endometrial polyps when compared to the control group. Abnormal parameters of carbohydrate metabolism indicate little sensitivity and specificity in predicting endometrial hyperplastic lesions. The insulin levels at 120 minutes of OGTT correlate best with such changes (concentration >57 microU/ml in case of hyperplasia and >61 microU/ml in endometrial polyps).
CONCLUSION: Insulin resistance and carbohydrate metabolism disturbances are common in women with endometrial pathologies. In these patients there is clinical basis for recommending lifestyle modification (change of diet, more physical activity), or for introduction of pharmaceutical insulin-sensitizing agents.

Entities:  

Mesh:

Year:  2013        PMID: 24455848     DOI: 10.17772/gp/1661

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  3 in total

1.  Clinical and Metabolic Response to Vitamin D Supplementation in Endometrial Hyperplasia: a Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Zohreh Tabassi; Sedigheh Bagheri; Mansooreh Samimi; Hamid Reza Gilasi; Fereshteh Bahmani; Maryam Chamani; Zatollah Asemi
Journal:  Horm Cancer       Date:  2017-03-10       Impact factor: 3.869

Review 2.  Antioxidative, Anti-Inflammatory, Anti-Obesogenic, and Antidiabetic Properties of Tea Polyphenols-The Positive Impact of Regular Tea Consumption as an Element of Prophylaxis and Pharmacotherapy Support in Endometrial Cancer.

Authors:  Piotr Olcha; Anna Winiarska-Mieczan; Małgorzata Kwiecień; Łukasz Nowakowski; Andrzej Miturski; Andrzej Semczuk; Bożena Kiczorowska; Krzysztof Gałczyński
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

3.  Odds ratio analysis in women with endometrial cancer.

Authors:  Katarzyna Plagens-Rotman; Ewa Żak; Beata Pięta
Journal:  Prz Menopauzalny       Date:  2016-03-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.